BAC vs NICE Stock Comparison

NICE currently leads BAC in this stock comparison, with AIQ scores of 68 vs 58. The clearest difference is momentum, while BAC has the stronger risk resilience profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 10 points
BAC
Financial Services
vs
NICE
Technology
BAC
Bank of America Corporation
Price
$51.02
Day move
+1.01%
AIQ Score
58/100
Best edge
Risk Resilience
Sector
Financial Services
NICE
NICE Ltd.
Leads
Price
$96.04
Day move
+2.04%
AIQ Score
68/100
Best edge
Momentum
Sector
Technology

What is the main difference between BAC and NICE?

NICE leads the current stock comparison as NICE Ltd., with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Bank of America Corporation vs NICE Ltd.

Data as of Nov 15, 2026· market close· Cross-sector · Financial Services vs Technology· Coverage 65/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 6/10

NICE leads

NICE leads by 10 AIQ points, primarily on Momentum and Value, and the lead has widened from 7 points over 30 sessions.

Competitive: 4 of 6 evidence groups support NICE, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 4 of 6Comparison trend: Strengthening
BAC

Bank of America Corporation

AIQ Score
58/100
AIQ Edge Score
6/10
NICE

NICE Ltd.

Leads
AIQ Score
68/100
AIQ Edge Score
9/10

The Algovestiq AIQ Score currently favors NICE over BAC, 68 versus 58 as of Nov 15, 2026. NICE's advantage is driven primarily by stronger momentum and value, while BAC holds the stronger risk resilience profile. NICE also shows the weaker technical structure relative to its 50-day moving average. 4 of 6 covered evidence groups favor NICE today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. NICE lead: Strengthening — the AIQ differential moved from 7 to 10 points over 30 sessions.

Compare Bank of America Corporation and NICE Ltd. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

BAC
+24.0%
NICE
-68.8%

Total return comparison

Growth of $10,000, distributions reinvested

BAC $12,399 · NICE $3,124

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare BAC and NICE against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BAC advantage
0
NICE advantage
  • Momentum37 vs 64
    NICE +27
  • Value68 vs 84
    NICE +16
  • Risk Resilience83 vs 67
    BAC +16
  • Quality64 vs 64
    Even

4 of 6 evidence groups favor NICE. NICE’s edge is concentrated in momentum and value; BAC keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

BAC0 AIQ

No factor moved materially.

New signals

  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
NICE-1 AIQ

Largest factor move: Value -2

New signals

  • OBV Bullish Divergence — bullish, volume, medium horizon (-14.4%)
  • RSI Bullish Divergence — bullish, momentum, medium horizon

NICE's lead narrowed by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — BAC and NICE both carry a full feed there.

The central trade-off

NICE (NICE Ltd.): the stronger current systematic profile, led by momentum and value.

BAC (Bank of America Corporation): the counter-case, on risk resilience, technicals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

NICE

NICE on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

NICE

NICE on combined revenue and EPS growth.

Value

NICE

NICE on the peer-relative Value factor, by 16 points.

Momentum

NICE

NICE on the Momentum factor, by 27 points.

Lower downside

BAC

BAC on Risk Resilience, by 16 points.

Analyst upside

NICE

NICE on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureBACNICENote
Implied upside to target+24.1%+57.2%NICE has more room
Target dispersion+25.3%+8.6%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering2514Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor NICE. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreNICE58 vs 68
FundamentalsNICEon balancerevenue growth -3.3% vs -1.4%; EPS growth -23.8% vs 12.5%; TTM ROE 2.3% vs 2.5%; gross margin 60.4% vs 64%; operating margin 22.4% vs 17% — NICE takes 3 of 4 decided legs, not all of them
ValuationNICEValue 68 vs 84
TechnicalsBACPrice vs 50-day -5.6% vs -12.2%; vs 200-day -7% vs -8%
Risk ResilienceBACRisk Resilience 83 vs 67
Analyst expectationsNICETarget upside 24.1% vs 57.2%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BAC and NICE and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is moderate at 10 points.
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on NICE.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

NICE lead: Strengthening — the AIQ differential moved from 7 to 10 points over 30 sessions.

May 27BAC leads above the line · NICE leads belowNov 13
Today
NICE +10
58 vs 68
7 sessions ago
NICE +14
58 vs 72
30 sessions ago
NICE +7
62 vs 69
90 sessions ago
BAC +10
71 vs 61

The lead changed hands once in this window, most recently on Sep 29 when NICE moved ahead of BAC.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BACConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only BAC

  • Bollinger Band Squeeze — neutral, volatility, short horizon (4.5%)
  • Death Cross Active — bearish, trend, long horizon (1.45%)
  • Downtrend Structure Active — bearish, trend, long horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
NICEConflicted

3 bullish / 1 bearish / 2 neutral, conflicted

Only NICE

  • Golden Cross Active — bullish, trend, long horizon (4.79%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.60%)
  • Keltner Channel Breakdown — bearish, volatility, short horizon
  • RSI Bullish Divergence — bullish, momentum, medium horizon

Both carry 1 more signal that do not separate them: OBV Bullish Divergence.

NICE leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BACNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.01%, AIQ 0 points).

NICEDivergence

Price is up while the AIQ Score moved down 1 points over the same session — price and model disagree (price +2.04%, AIQ -1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1BAC closes the Momentum gap — currently 27 points behind, the largest single contributor to NICE's edge.
  2. 2BAC's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3NICE's conflicting signal state resolves bearish — it currently carries 3 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

NICE leads on balance
MetricBACNICE
Revenue growth (YoY)-3.3%-1.4%
EPS growth (YoY)-23.8%12.5%
Gross margin60.4%64%
Operating margin22.4%17%
Return on equity (TTM)2.3%2.5%
Debt to equity1.280.02

Performance

BAC leads 4 of 6 windows
MetricBACNICE
1 week (5 sessions)3.2%-0.1%
1 month (20 sessions)-0.4%-14.4%
3 months (63 sessions)-20.1%-1.9%
6 months (126 sessions)2.5%7%
Year to date-7.2%-15%
1 year (252 sessions)-5.7%-22.7%

Technicals

BAC has the stronger structure
MetricBACNICE
RSI (14)45.932.7
ADX (14)27.232
Price vs 50-day-5.6%-12.2%
Price vs 200-day-7%-8%
Volatility (1M, annualized)24.8%40.3%

Risk

BAC is the more resilient
MetricBACNICE
Beta0.790.26
Sharpe ratio-0.22-0.38
Sortino ratio-0.29-0.52
Max drawdown-23.7%-37.7%
Current drawdown-21.3%-28%
Annualized volatility22.4%54.1%
Value at risk (95%)-2.6%-4.9%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, BAC or NICE?

On the Algovestiq AIQ Score, NICE is the stronger of the two as of Nov 15, 2026, scoring 68 against BAC's 58. The edge comes from momentum and value. BAC is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is BAC or NICE the better buy right now?

NICE carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor NICE over BAC?

The composite weights Quality, Value, Momentum and Risk Resilience. NICE leads Momentum by 27 points; NICE leads Value by 16 points; BAC leads Risk Resilience by 16 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, BAC or NICE?

Analyst price targets imply +24.1% upside for BAC and +57.2% for NICE, so the Street currently favors NICE. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BAC or NICE?

NICE is the better-valued of the two on the peer-relative Value factor. NICE on the peer-relative Value factor, by 16 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BAC or NICE?

NICE on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BAC or NICE?

NICE on the Momentum factor, by 27 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BAC or NICE?

BAC is the more resilient of the two, so the other name carries the higher downside risk. BAC on Risk Resilience, by 16 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BAC more profitable than NICE?

The profitability evidence is mixed: gross margin 60.4% vs 64%; operating margin 22.4% vs 17%; ttm roe 2.3% vs 2.5%. Each name leads on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is NICE's lead over BAC getting stronger or weaker?

NICE lead: Strengthening — the AIQ differential moved from 7 to 10 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-09-29, when NICE moved ahead of BAC.

What would change the BAC vs NICE verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BAC closes the Momentum gap — currently 27 points behind, the largest single contributor to NICE's edge; BAC's Death Cross Active resolves — a bearish trend rule currently active against it; NICE's conflicting signal state resolves bearish — it currently carries 3 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about BAC and NICE?

BAC: 2 bullish / 2 bearish / 1 neutral, conflicted. NICE: 3 bullish / 1 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BAC is Death Cross Active (bearish, long horizon). On NICE it is Golden Cross Active (bullish, long horizon).

Compare BAC and NICE with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.